Fast Five Quiz: Cancer-Associated Venous Thromboembolism (VTE)

Kenneth A. Bauer, MD


March 17, 2020

Chemotherapy may increase the risk for VTE by affecting the vascular endothelium, coagulation cascades, and tumor cell lysis. The incidence was shown to increase in patients undergoing longer courses of chemotherapy for breast cancer.

Cancer is noted in up to 30% of patients with VTE. The thrombogenic mechanisms involve abnormal coagulation, as evidenced by abnormal coagulation factors present in 90% of patients with cancer.

Learn more about cancer-associated VTE.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: